Gc globulin and prealbumin serum levels in patients with cancer and benign inflammatory diseases and in asymptomatic smokers.
Gc globulin and prealbumin serum levels were determined in a coded serum panel from the National Cancer Institute-Mayo Clinic. Serum samples came from 100 patients with cancer (lung, prostate gland, or gastrointestinal tract), from 50 patients with benign inflammatory diseases from the same organs as those of the cancer patients, and from 50 clinically healthy smokers. No differences were observed among groups in the Gc globulin (vitamin D carrier) serum concentrations; however, prealbumin (vitamin A carrier) serum levels were decreased for patients with benign inflammatory diseases and for cancer patients; the cancer group showed the greatest decrease.
D000510:Alpha-Globulins / Q000032:analysis*; D002352:Carrier Proteins / Q000097:blood*; D005260:Female; D006023:Glycoproteins / Q000097:blood; D006801:Humans; D007249:Inflammation / Q000097:blood*; D008297:Male; D009369:Neoplasms / Q000097:blood* / Q000188:drug therapy; D011228:Prealbumin / Q000032:analysis*; D012709:Serum Albumin / Q000032:analysis*; D012907:Smoking / Q000503:physiopathology*; D014801:Vitamin A / Q000627:therapeutic use; D014807:Vitamin D / Q000097:blood
D000510:Alpha-Globulins; D002352:Carrier Proteins; D006023:Glycoproteins; D011228:Prealbumin; D012709:Serum Albumin; D014801:Vitamin A; D014807:Vitamin D